Andy is the Managing Director and co-founder of Antibody Analytics. He started his scientific career working at Medimmune UK working in the Quality Control Department that was responsible for release of live, attenuated Influenza vaccine. In 2005, he moved to Covance Laboratories where he become the senior Bioassay Scientist responsible for development and validation of range of cell based functional methodologies for GMP lot release as well as assessment of neutralising anti-drug antibodies in patient samples working with a diverse range of biologic drug products. In 2007, Andy was a founding member and the first employee of BioOutsource Ltd in Glasgow, where he was employed until December 2015. During this time, Andy has held multiple positions throughout the organisation, establishing the operational divisions, defining the R&D and operational strategies. Andy is considered an industry expert in the characterisation of biosimilar monoclonal antibodies having worked with over 25 different companies across ten different biosimilar molecules and has presented at international conferences, participated in seminars and prepared publications on the topic.